Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study

• by Erwin Lankes, Levin Wiebelt, Kathrin Bettina Helge, Dirk Schnabel, Peter Kühnen, Oliver Blankenstein, Uta Neumann

• July 7, 2026

Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis

• by Wendi Cao, Qingxi Rong, Yingheng Song, Zhijun Ma, Qiuxia Dong

• July 21, 2026

How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.

• by Andrea Surnit

• August 12, 2026

• 3 min

A network meta-analysis of endocrine adverse events induced by immune checkpoint inhibitors in colorectal cancer

• by Boyu Chen, Jing Liu, Kexin Gan, Liqun Yang, Peng Qiu, Boqing Ma, Wen Chen

• July 10, 2026